ArticleCancers2024

Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-Analysis of the Collaborative Ocular Melanoma Study (COMS) and Natural History Study (NHS) Cohorts.

Hans Witzenhausen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.